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ABSTRACT
Among the three mammalian genes encoding DNA
ligases, only the LIG3 gene does not have a homolog
in lower eukaryotes. In somatic mammalian cells,
the nuclear form of DNA ligase IIIa forms a stable
complex with the DNA repair protein XRCC1 that
is also found only in higher eukaryotes. Recent
studies have shown that XRCC1 participates in S
phase-specific DNA repair pathways independently
of DNA ligase IIIa and is constitutively phos-
phorylated by casein kinase II. In this study we
demonstrate that DNA ligase IIIa, unlike XRCC1, is
phosphorylated in a cell cycle-dependent manner.
Specifically, DNA ligase IIIa is phosphorylated on
Ser123 by the cell division cycle kinase Cdk2
beginning early in S phase and continuing into M
phase. Interestingly, treatment of S phase cells with
agents that cause oxygen free radicals induces the
dephosphorylation of DNA ligase IIIa. This oxidative
stress-induced dephosphorylation of DNA ligase IIIa
is dependent upon the ATM (ataxia-telangiectasia
mutated) kinase and appears to involve inhibition of
Cdk2 and probably activation of a phosphatase.
INTRODUCTION
DNA ligases are critical enzymes in DNA metabolism
because of their role in the completion of DNA replication,
repair and recombination. In mammals, three genes encoding
ATP-dependent DNA ligases, designated LIG1, LIG3 and
LIG4, have been identiﬁed (1). The LIG3 gene is unusual
for the following reasons. Firstly, unlike LIG1 and LIG4,
there are no homologs of LIG3 in lower eukaryotes such as
Saccharomyces cerevisiae. Secondly, as described below,
the LIG3 gene generates several distinct gene products. In
somatic cells, the use of alternative translation initiation
start sites generates nuclear and mitochondrial forms of
DNA ligase IIIa (2) whereas an alternative germ cell-speciﬁc
splicing mechanism generates DNA ligase IIIb, which has a
different C-terminal amino acid sequence than DNA ligase
IIIa (3).
The discovery that DNA ligase IIIa forms a stable complex
with the DNA repair protein, XRCC1, which is involved
in base excision repair (BER) and the repair of DNA single-
strand breaks, provided the ﬁrst insights into the cellular
functions of the LIG3 gene products (4). In subsequent stud-
ies it was shown that complex formation occurs via inter-
actions between the C-terminal BRCT motifs of XRCC1
and DNA ligase IIIa (3,5,6) and that XRCC1 is necessary
for the stability and activity of DNA ligase IIIa in vivo (7).
Since xrcc1 mutant cells are deﬁcient in DNA ligase IIIa
activity, the phenotype of these cells is likely to be, at least
in part, a consequence of reduced DNA joining.
Although XRCC1 has no catalytic activity, it appears to
co-ordinate the activities of proteins involved in BER and
the repair of DNA single-strand breaks via protein–protein
interactions (4,8–14). More recently, it has been found that
XRCC1 also interacts with aprataxin (15–17), a protein
which is required to prevent ataxia ocular apraxia (18).
Intriguingly, both XRCC1 and DNA ligase IIIa appear to
be components of two different complexes, one of which con-
tains known DNA repair protein partners of XRCC1 whereas
the other complex contains aprataxin (19). Since reduced cel-
lular levels of aprataxin result in reduced levels of XRCC1
and increased DNA damage sensitivity (19), it appears that
aprataxin stabilizes XRCC1 (and presumably DNA ligase
IIIa), thereby indirectly regulating the base excision and
single strand break repair pathways.
XRCC1 functions independently of DNA ligase IIIa in a
DNA repair pathway that plays a major role in the repair of
DNA damage induced by DNA alkylating agents in replicat-
ing cells (20). Moreover, XRCC1 does not appear to be
involved in the function of DNA ligase IIIa in mitochondrial
DNA metabolism (21). Thus, the role of DNA ligase IIIa in
maintaining genome stability and cell viability cannot be
deduced from the phenotype of xrcc1 mutant cells. Here we
show that, in contrast to the constitutive phosphorylation
*To whom correspondence should be addressed. Radiation Oncology Research Laboratory, Department of Radiation Oncology, and Marlene and Stewart
Greenebaum Cancer Center, University of Maryland School of Medicine, 655 W. Baltimore St., Baltimore, MD 21201-1509, USA. Tel: +1 410 706 2365;
Fax: +1 410 706 3000; Email: atomkinson@som.umaryland.edu
  2006 The Author(s).
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Published online 12 October 2006 Nucleic Acids Research, 2006, Vol. 34, No. 20 5721–5729
doi:10.1093/nar/gkl705of XRCC1 by casein kinase II (22), DNA ligase IIIa is spe-
ciﬁcally phosphorylated in replicating cells by the cell cycle
kinase Cdk2. However, in response to oxidative DNA dam-
age, DNA ligase IIIa is dephosphorylated in a pathway that
is dependent upon the DNA damage-activated, phosphatidyli-
nositol 3-phosphate (PI3)
1-related kinase ATM.
MATERIALS AND METHODS
Cell culture
The human cancer cell lines, T24 and HeLa were obtained
from America Type Culture Collection and cultured in
DMEM with low glucose (1 mg/ml) plus 10% fetal bovine
serum. Cultures of T24 cells were synchronized by density
arrest and then replated at a lower density to allow the cells
to synchronously re-enter the cell cycle. To obtain M phase
cells, nocodazole was added to the medium 26 h after replat-
ing and incubation continued for 5–8 h (23). The progression
of T24 cells through the cell cycle was monitored by the
phosphorylation status of the retinoblastoma protein (23)
and conﬁrmed by FACS analysis (data not shown). HeLa
cells were synchronized in S phase by double thymidine treat-
ment as described (24). A population of cells enriched for the
G1 phase was prepared by releasing the nocodazole-arrested
G2/M cells and allowing them to progress into G1.
The cell lines, FT/pEBS7 and FT/pEBS7-YZ5 were
derived from immortalized human ﬁbroblast AT22IJE-T,
which contains homozygous frameshift mutations in the
ATM gene, by transfection with the empty vector (pEBS7)
and a recombinant vector expressing wild type ATM, respec-
tively (25). The cells lines were cultured in DMEM with low
glucose (1 mg/ml) plus 10% fetal bovine serum.
Cell cultures were treated with various genotoxic agents.
For g irradiation, cells were exposed at a rate of 2.5 Gray/min
in an Irradiator (Mark I, model 68A, JL Shepherd & Assoc.)
and then harvested 1 h post-irradiation. The DNA alkylating
agent ethyl methanesulfonate (EMS) and the oxidizing agents
menadione and hydrogen peroxide (30% w/w solution) were
from Sigma. Cells were treated with either EMS, hydrogen
peroxide or menadione for 1 h. To induce oxidative stress,
glucose oxidase was added at various concentrations to
cells cultured in DMEM with high glucose (4.5 mg/ml).
After 1 h of incubation, the cells were harvested. Wortmannin
(Sigma) was added 30 min before exposure to the damaging
agent to inhibit PI3 kinases (26).
Immunoblotting and antibodies
Cellswereharvestedandlysedinlysisbuffer[50mMTris–HCl
(pH 7.5), 150 mM NaCl, 0.1% NP-40, 1mM phenylmethylsul-
fonyl ﬂuoride and 1 mM NaF]. After centrifugation at 14 000 g
for 5 min, aliquots of the cleared lysates were resolved
bysodium dodecyl-polyacrylamide gel (8.5% polyacrylamide,
17 · 22 cm gel) electrophoresis (SDS–PAGE) and then trans-
ferred to a nitrocellulose membrane (Optitran, Schleicher &
Schuell) prior to incubation with the indicated antibody.
Antigen-antibody complexes were detected by either
enhanced chemiluminescence (ECL, Pierce) or an alkaline
phosphatase/colorimetric assay (AP, Bio-Rad). Antibodies
against DNA ligase III (1F3, monoclonal) and XRCC1
(rabbit polyclonal) antibodies were from GeneTex. Antibod-
ies against Cdk6, Cdk2 and Cdc2 were from Santa Cruz
Biotechnology. Antibody against human Rb protein
(RBmAb11D7), a gift from Dr Phang-Lang Chen, was
used to verify cell cycle status. Enzyme-linked secondary
antibodies were from Bio-Rad. Antibodies against cyclin
A and B are from Santa Cruz Biotechnology. a-phos-
Ser123, antiserum against a DNA ligase III peptide (amino
acid 116–130) encompassing phosphorylated Ser123 was
also generated and afﬁnity puriﬁed (Bethyl Laboratories).
Immunoprecipitations
Cleared cell lysates, prepared as described above, were mixed
with the indicated antibody and protein G (or A) Sepharose
beads equilibrated with lysis buffer. After incubation at 4 C
with constant rolling, the beads were collected and washed
extensively with lysis buffer. Proteins were eluted from the
beads by incubation in SDS sample buffer for 5 min at
100 C and then separated by SDS–PAGE.
Phosphatase assays
Cleared cell lysates were prepared as described above
except that NaF was omitted from the lysis buffer. The
lysates were incubated with or without the indicated phos-
phatase (lambda phosphatase or calf intestinal phosphatase,
NEB) at 30 C for 30 min. Where indicated, the nonspeciﬁc
phosphatase inhibitor NaF (1 mM) was also included in this
assay to demonstrate that changes in mobility were caused
by phosphatase action. Similarly, DNA ligase IIIa was
co-immunoprecipitated with XRCC1 antibodies and protein
G beads from cell lysates as described above. Proteins
bound to the protein G beads were incubated with calf
intestine phosphatase (NEB ) at 37 C for 60 min. After sep-
aration by SDS–PAGE, DNA ligase III was detected by
immunoblotting.
Kinase assays
Cells were harvested and lysed in TGN buffer [50 mM
Tris–HCl (pH 7.5), 150 mM NaCl, 1% Tween-20 (v/v),
0.2% NP-40 (v/v), 1 mM NaF, 1 mM sodium orthovanadate,
1 mM phenylmethylsulfonyl ﬂuoride, 10 mg/ml aprotinin,
2 mg/ml pepstatin]. Cleared lysates (2 mg protein) were incu-
bated with 30 ml protein G Sepharose beads for 1 h with con-
stant rolling at 4 C. After removing the beads, antibodies
against Cdk2, Cdk6 and Cdc2 (Santa Cruz Biotechnology)
were added and incubation continued. After 1 h, protein G
Sepharose beads (20 ml) were added and incubation continued
for 2 h. Beads were collected, washed with TGN buffer and
then with Cdk buffer (50 mM HEPES (pH 7.5), 30 mM NaCl,
4 mM MnCl2, 6 mM MgCl2, 10% glycerol, 1 mM DTT and
100 mM sodium orthovanadate). For each kinase assay, the
beads were incubated with 1 mg of substrate protein, 20 mM
ATP and 10 mCi [g-
32P]ATP in Cdk buffer for 15 min at
30 C. After separation by SDS–PAGE (10% polyacrylamide,
7 · 8 cm gel), labeled proteins were detected in the dried gel
by phosphorimager analysis. Cdk6 substrate, an Rb fragment
corresponding to amino acids 769–921 of mouse Rb, was
from Santa Cruz Biotechnology. Cdk2 and Cdc2 substrate,
histone H1 was from Sigma.
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Wild type and dominant negative Cdk2 cDNAs (27) were
subcloned in-frame with an HA-tag into the mammalian
expression vector pRC/RSV (Invitrogen) to generate pRCH-
cdk2(wt) and pRCH-cdk2(dn). The plasmid pQE32 (Qiagen)
was used to express all versions of his-tagged DNA ligase
IIIb. The pQE32 plasmid expressing full length DNA ligase
IIIb was described previously (28,29). Various truncated
versions of DNA ligase IIIb cDNA were subcloned into
pGEX-4TtogenerateplamidsexpressingGSTfusionproteins.
PCR-based site directed mutagenesis was performed using
DNA ligase IIIb cDNA as a template. Three primers were
designed for mutation of each of the three putative Cdk sites:
Thr104/Ala, Ser123/Ala and Ser826/Ala. The sequences
of these primers are listed. Primer pair I, 50-GTCTTC-
TAAGGCA(T)GCAGGTA(G)CACCAAAGAAGAAAGC-30;
50-GCTTTCTTCTTTGGTGCACCTGCAGCCTTAGAAG-
AC-30. To facilitate identiﬁcation of mutants, a PstI site
was introduced by replacing GCA with GCT. This mutation
does not affect amino acid sequence. Similarly, a HindIII
site was introduced into the second and third primers
without changing the amino acid sequence. Primer pair II 50-
CCAGGCTAAGT(C)TG(T)ACAACCACTGGCCAGGTG-
ACTT(G)CTCCAGTGAAAG-30;5 0-CTTTCACTGGAGC-
AGTCACCTGGCCAGTGGTTGTAAGCTTAGCCTGG-30.
Primer pair III, 50-GGGGAGAAGCTG(T)GCCACAAAGT-
CTT(G)CTCCAGTGAAAGTAG-30;5 0-CTACTTTCACT-
GGAGCAGACTTTGTGGCAAGCTTCTCCCC-30.A m p l i -
ﬁcation was carried out in a 50 ml volume containing 50 ng
of plasmid DNA, 200 mM dNTPs, 125 nM primers, 1 ml Pfu
buffer (Stratagene), and 2.5 U of Pfu DNA polymerase. A
pre-incubation at 95 C for 30 s was performed, followed by
16 cycles of 95 C for 30 s, 55 C for 1 min, and 68 C for
15 min. The PCR products were veriﬁed by agarose gel elec-
trophoresis and treated with the restriction endonuclease
DpnI at 37 C for 1 h to remove template plasmids. An
aliquot (1 ml) from each reaction was used for transfor-
mation of competent bacterial cells. LB plates contain-
ing isopropyl-b-D-thiogalactopyranoside (0.1 mM) and 5-
bromo-4-chloro-3-indolyl-b-D-galactoside (0.1 mg/ml) were used
for selection. Plasmids bearing mutations were selected and
veriﬁed by restriction enzyme digestion and DNA sequencing.
Expression and purification of his-tagged and
GST fusion proteins
Wildtypeandmutationversionsofhis-taggedDNAligaseIIIb
were overexpressed in Escherichia coli and puriﬁed as
described previously (28,29).Theplasmid pGEX-4Tencoding
truncated versions of DNA ligase III as GST fusions were
transformed into E.coli BL-21 competent cells. Expression of
GSTfusionproteinswasinducedbyIPTGandveriﬁedbyCoo-
massie blue staining after SDS–PAGE. The puriﬁcation of
taggedproteinswascarriedoutasdescribedpreviously(28,29).
RESULTS
DNA ligase IIIa is phosphorylated during S phase
The recent observations that the contributions of XRCC1
and DNA ligase IIIa to the repair of DNA damage differ
depending on cell cycle stage (20) and that XRCC1 is
constitutively phosphorylated by casein kinase II (22)
prompted us to examine whether DNA ligase IIIa is subject
to post translational modiﬁcation during cell cycle progres-
sion. In initial studies, density-arrested human T24 cells
derived from a bladder carcinoma were stimulated to syn-
chronously re-enter the cell cycle by replating at a lower den-
sity (23). The cell cycle regulatory protein, Rb, which
becomes hyper-phosphorylated during the cell cycle progres-
sion, has been used as an indicator of cell cycle stage (23). As
expected, Rb is increasingly phosphorylated as the T24 cell
population proceeds through the cell cycle (Figure 1A, left
panel). The cellular levels of XRCC1 (Figure 1A, right
panel) and DNA ligase IIIa (Figure 1A, left panel) did not
change signiﬁcantly as the cell population progressed through
the cell cycle stages. However, a form of DNA ligase IIIa
with reduced mobility was initially detected  6–12 h after
replating, which corresponds to when the cells are transition-
ing from G1 to S phase (23). This form accumulated as the
cell population progressed through the cell cycle with a con-
comitant reduction of the major form of DNA ligase IIIa
detected in early G1 cells (Figure 1A).
To demonstrate that the change in mobility of DNA ligase
IIIa is not cell-type speciﬁc, we examined extracts of
human HeLa cells enriched for different cell cycle stages by
treatment with chemical inhibitors of cell cycle progression
Figure 1. DNA ligase IIIa is phosphorylated during cell cycle progression.
(A) Human T24 cells were synchronized by density arrest. Aliquots of the
culture were removed at the times indicated after replating at a lower density.
The addition of nocodazole (Noc) blocked cells at G2/M. DNA ligase IIIa,
Rb, (left panel) b-actin and XRCC1 (right panel) were detected in cell extracts
by immunoblotting. The phosphorylation status of Rb serves as an indicator of
cell cycle progression (23). (B) HeLa cell populations were enriched for the
G1 (G1), G2/M (Noc) and S phases (DT) of the cell cycle as described in
Materials and Methods section. DNA ligase IIIa was detected in the extracts
by immunoblotting. (C) Cell extracts were prepared from asynchronous
CHO cells (As) and CHO cells treated with hydroxyurea (Hu) and nocodazole
(Noc). DNA ligase III was detected by immunoblotting. (D) Aliquots of an
extract from an asynchronous population of T24 cells were incubated as
indicated with l phosphatase (l) either in the presence (+) or absence ( )o f
the phosphatase inhibitor, NaF for 30 min at 37 C. DNA ligase IIIa was
detected by immunoblotting. (E) DNA ligase IIIa was co-immunoprecipitated
with XRCC1 antibody from an S phase HeLa cell extract. The immuno-
precipitate was incubated with (+) or without ( ) calf intestinal phos-
phatase (CIP) prior to the detection of DNA ligase IIIa by immunoblotting.
Nucleic Acids Research, 2006, Vol. 34, No. 20 5723(Figure 1B). In accord with the studies described above
(Figure 1A), a DNA ligase IIIa doublet was detected in
extracts of HeLa cells enriched for early S phase by double
thymidine block (Figure 1B). In extracts from cell pop-
ulations enriched for M phase by nocodazole treatment,
the upper band of the doublet was the major species whereas
the lower band of the doublet was the major species in
extracts from cell populations enriched for G1 phase by
releasing cells arrested in M phase by nocodazole
(Figure 1B). Similar cell cycle-dependent changes in the
mobility of DNA ligase IIIa were observed in experiments
with Chinese Hamster Ovary cells (Figure 1C).
Incubation of extracts from cell populations enriched for
S phase with l phosphatase resulted in a reduction in the
upper band of the DNA ligase IIIa doublet and a comcomi-
tant increase in the lower band (Figure 1D). A similar result
was obtained when DNA ligase IIIa was immunoprecipitated
from S phase cell extracts with an XRCC1 antibody and
then incubated with calf intestinal phosphatase (Figure 1E).
Together these results demonstrate that DNA ligase IIIa is
phosphorylated when cells enter S phase with an increasing
fraction of DNA ligase IIIa complexed with XRCC1 becom-
ing phosphorylated as the cells progress through the S and G2
phases of the cell cycle. During the transition from mitosis
into the G1 phase of the next cell cycle, DNA ligase IIIa is
dephosphorylated.
Cdk2 phosphorylates DNA ligase III in vitro and in vivo
The pattern of DNA ligase IIIa phosphorylation suggests that
it may be a substrate for one of the cell cycle-regulated
cyclin-dependent kinases (CDKs). Indeed, a search of the
mammalian DNA ligase IIIa amino acid sequence for
regions that are homologous to the consensus CDK site
(Figure 2A) revealed three putative CDK sites that are con-
served in the human and mouse enzymes (Figure 2A). To
determine which of the CDK(s) phosphorylates DNA ligase
III, Cdk6 and Cdk2 were immunoprecipitated from extracts
of an asynchronous HeLa cell population. Although both
these kinases phosphorylated their native substrate, Rb pro-
tein fragment and histone H1, respectively (Figure 2B),
only Cdk2 phosphorylated DNA ligase III in vitro. This result
is consistent with the observed phosphorylation of DNA
ligase IIIa in S phase (Figure 1) because Cdk2 is active in
both the S and G2 phases of the cell cycle whereas Cdk6
is a G1 phase kinase. Since DNA ligase IIIa is also
phosphorylated in M phase (Figure 1), we asked whether
Cdc2, a cyclin-dependent kinase active in G2/M, can also
phosphorylate DNA ligase III. As expected, activity Cdk2
was co-immunoprecipitated with cyclin A from S and
G2/M extracts whereas robust Cdc2 activity was only
co-immunoprecipitated with cyclin B from a G2/M extract
of synchronized human T24 cells (Figure 2C). The immuno-
precipitated Cdk2 and Cdc2 kinases phosphorylated both
histone H1 and DNA ligase III (Figure 2D).
Since DNA ligase IIIa is fully phosphorylated during cell
progression prior to the the presence of robust Cdc2 activity,
we focused on mapping the DNA ligase III sites phosphory-
lated by Cdk2. Several truncated versions of DNA ligase III
were expressed as GST fusion proteins and puriﬁed by afﬁn-
ity chromatography (Figure 3A). When these fragments were
Figure 2. Cdk2 phosphorylates DNA ligase III in vitro.( A) The consensus motif recognized by CDKs is shown with conserved putative CDK phosphorylation
sites in mouse and human DNA ligase III below. (B) In the upper panel, Cdk6 and Cdk2 were immunoprecipitated from asynchronous HeLa cell extracts. In vitro
kinase assays were performed with [g-
32P]ATP using an Rb fragment (Santa Cruz) or histone H1 (Sigma) as phosphorylation substrates. The protein kinase
substrates were detected by Coomassie blue staining and phosphorimaging. In the lower panel, in vitro phosphorylation of DNA ligase III by Cdk6 and Cdk2
immunoprecipitated from asynchronous HeLa cell extracts was detected by phosphorimaging. (C) T24 cells density-arrested in G0 were released into the
cell cycle and harvested at 6 h (G1) or 24 h (S). Cells were treated with nocodazole as described in Materials and Methods section to obtain G2/M enriched cells.
In the upper and middle panels, Cdk2, Cdc2, cyclin A and cyclin B were detected in the cell extracts by immunoblotting. In the lower left panel, Cdk2
co-immunoprecipitated with cyclin A antibody (IP) from the indicated cell extract was detected by immunoblotting (IB). In the lower right panel, Cdc2
co-immunoprecipitated with cyclin B antibody (IP) from the indicated cell extract was detected by immunoblotting (IB). (D) Phosphorylation of histone H1 and
DNA ligase III by CDK kinases immunoprecipitated with cyclin A (left panel) and cyclin B (right panel) antibodies from the indicated extracts. The protein
kinase substrates were detected by Coomassie blue staining and phosphorimaging.
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an N-terminal fragment containing two of the three putative
CDK sites (Thr104 and Ser123) was efﬁciently phosphory-
lated by Cdk2, whereas a fragment containing the third
putative CDK site (Ser826) was phosphorylated to a much
lesser extent (Figure 3B). To determine whether Cdk2 was
indeed phosphorylating the putative CDK sites in vitro,w e
used site-directed mutagenesis to change the key serine or
threonine residues to alanine. Replacement of Ser123 greatly
reduced DNA ligase III phosphorylation whereas replacement
of both Thr104 and Ser826 had only a minor effect on DNA
ligase III phosphorylation. Together these results show that
DNA ligase III is speciﬁcally phosphorylated by Cdk2 and
Cdc2 in vitro and that Ser123 is the major site of phosphory-
lation by Cdk2.
To demonstrate that Ser123 of DNA ligase III is phospho-
rylated in vivo, we generated an antibody against a DNA
ligase III peptide (residues 116–130) encompassing phospho-
rylated Ser123. As expected, the phosphopeptide antibody
preferentially recognized DNA ligase III that had been phos-
phorylated in vitro by immunoprecipitated Cdk2 (Figure 4A).
In this experiment, we did not detect phosphorylation of DNA
ligase III by Cdk2 immunoprecipitated by cyclin B antibody,
presumably because of the low levels of the G2/M kinase in
an extract from asynchronous cells. Next we examined the
reactivity of DNA ligase in extracts in G1 and S phase cell
extracts with the phosphopeptide antibody by immunoblot-
ting. As expected, the DNA ligase III monoclonal antibody
that recognizes both phosphorylated and unphosphorylated
DNA ligase III, detected a DNA ligase III doublet in the
S phase extract but similar total levels of DNA ligase III pro-
tein were present in both cell extracts (Figure 4B). In con-
trast, only the S phase extract contained versions of DNA
ligase III recognized by the phosphopeptide antibody under
these conditions (Figure 4B), indicating that Ser123 is
phosphorylated in vivo.
To conﬁrm that Cdk2 phosphorylates DNA ligase IIIa in
vivo, we transiently overexpressed wild type Cdk2 and a
dominant negative version (Cdk2 dn), which interacts with
cyclins but lacks kinase activity (27). In cells overexpressing
HA-tagged Cdk2 dn, there were markedly reduced levels of
phosphorylated DNA ligase III compared with cells trans-
fected with the empty expression vector (Figure 4C). By
contrast, overexpression of HA-tagged wild type Cdk2 did
not signiﬁcantly change the levels of the phosphorylated
and dephosphorylated DNA ligase IIIa (Figure 4C). Thus,
we conclude that Cdk2 phosphorylates DNA ligase IIIa
in vivo.
Dephosphorylation of DNA ligase IIIa is induced
by oxidative stress
Having established the pattern of DNA ligase IIIa phosphory-
lation as a function of cell cycle stage, we next examined
whether DNA damage inﬂuences the post-translational modi-
ﬁcation of this enzyme. In experiments with G1 cells, we
wereunabletodetectachangeinthemobilityofthedephospho-
rylatedform ofDNA ligase IIIafollowingtreatmentwith vari-
ous DNA damaging agents (data not shown). However,
treatment of an S phase-enriched population of HeLa cells
Figure 3. Mapping the DNA ligase III sites phosphorylated in vitro by Cdk2. (A) The indicated fragments of DNA ligase III were expressed as GST fusion
proteins. The grey and black boxes mark the positions of the N-terminal zinc finger and C-terminal BRCT domain, respectively. (B) Purified GST and the GST
fusion proteins were incubated with immunoprecipitated Cdk2 and [g-
32P]ATP. (C) Wild type (wt) and mutant versions of DNA ligase III (S123/A and T104/A,
S286/A), in which putative amino acid targets for Cdk2 phosphorylation were replaced with alanine, were incubated with immunoprecipitated Cdk2 and
[g-
32P]ATP. After separation by SDS–PAGE, unlabeled proteins were visualized by Coomassie blue staining [upper panel in both (B) and C)] and labeleled
proteins by phosphorimager analysis [lower panel in both (B) and (C)].
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HeLa cells and from cells that had been either exposed to 10 Gy of ionizing radiation (IR) or 0.5% EMS (EMS) by immunoblotting. (B) Asynchronous
HeLa cells were treated with the indicated concentrations of EMS and doses of IR. DNA ligase III in extracts from the damaged and undamaged (con) cell
extracts was detected by immunoblotting with the antibody (a-phos-Ser123) raised against a DNA ligase III peptide (residues 116–130) encompassing
phosphorylated Ser123. To control for protein loading, b-actin in the extracts was detected by immunoblotting. (C) Populations of HeLa cells enriched
for S phase as described in Materials and Methods section were either mock treated or treated with 12 Gy of ionizing radiation (IR). DNA ligase III was
detected in the cell extracts either directly by immunoblotting (upper panel) or by co-immunoprecipitation with an XRCC1 antibody followed
by immunoblotting (lower panel). (D) S phase-enriched HeLa cells were treated with either hydrogen peroxide (H2O2, upper panel), menadione (MN,
middle panel) or glucose oxidase (GOX, lower panel) as described in Material and Methods section. DNA ligase III was detected in cell extracts by
immunoblotting.
Figure 4. Cdk2 phosphorylates DNA ligase III in vivo.( A) Proteins were immunoprecipitated with Cdk2, cyclin A or cyclin B antibodies from extracts of
asynchronous HeLa cells. The immunoprecipitates were incubated with purified DNA ligase III and histone H1 in the presence of [g-
32P]ATP. DNA ligase III
was detected by immunblotting with the DNA ligase III monoclonal antibody IF3 that recognizes unmodified and phosphorylated DNA ligase III and the
antibody (a-phos-Ser123) raised against a DNA ligase III peptide (residues 116–130) encompassing phosphorylated Ser123. Purified histone H1 (Sigma) was
detected by Coomassie blue staining. Labeled DNA ligase III and histone H1 were detected by phosphorimaging. (B) DNA ligase III from G1 (G1) and S (S)
phase T24 cells was detected by immunoblotting with either 1F3 or a-phos-Ser123. (C) HeLa cells were transfected with expression vectors expressing HA-
tagged versions of wild type (Cdk2-wt) and dominant negative cdk2(dn) (Cdk2-dn), and the empty expression vector (vector). HA-tagged Cdk2 and DNA ligase
III were detected in cell extracts by immunoblotting.
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EMS resulted in the dephosphorylation of DNA ligase IIIa
(Figure 5A). Using the phosphopeptide antibody, we failed to
detect EMS-induced dephosphorylation of DNA ligase III at
concentrations ranging from 0.01 to 0.1% EMS whereas expo-
sure to1GrayofIR inducedDNA ligaseIII dephosphorylation
(Figure 5B). DNA ligase IIIa molecules immunoprecipitated
by XRCC1 antibody were dephosphorylated in response to IR
demonstratingthat,asshownpreviously(Figure1),DNAligase
IIIa complexed with XRCC1 is being modiﬁed and that
complex formation with XRCC1 is not inﬂuenced by the phos-
phorylation status of DNA ligase IIIa (Figure 5C).
The ability of IR but not EMS to induce DNA ligase III
dephosphorylation was surprising because xrcc1 mutant
cells are much more sensitive to DNA alkylating agents
than IR (30,31). Although IR directly causes DNA strand
breaks, oxygen free radicals generated by the IR account
for a signiﬁcant fraction of DNA lesions. To determine
whether oxidative stress is involved in the dephosphorylation
of DNA ligase IIIa, cells were incubated with hydrogen
peroxide, menadione and glucose oxidase. As shown in
Figure 5D, each of these agents efﬁciently induced DNA
ligase IIIa dephosphorylation indicating that active oxygen
species are involved in this event.
ATM mediates oxidative stress-induced
dephosphorylation of DNA ligase IIIa
Three protein kinases, DNA-PKcs, ATR and ATM, which
resemble PI3 kinases, have been implicated in the cellular
response to DNA damage (32). To determine whether one or
more of these enzymes is involved in the oxidative stress-
induced dephosphorylation of DNA ligase IIIa, we utilized
wortmannin, an inhibitor of PI3 kinases (33). As shown in
Figure 6A, wortmannin inhibited hydrogen peroxide-induced
dephosphorylation of DNA ligase IIIa (Figure 6A), indicating
theinvolvementofaPI3kinaseinthisevent.Nextweusedgen-
eticallydeﬁned pairsofcelllines todeterminethe roleofATM
(25), ATR (34) and DNA-PK (35) in the oxidative stress-
induced dephosphorylation of DNA ligase IIIa. Neither the
overexpression of a dominant negative, kinase-dead version
of ATR (34) nor the absence of DNA-PKcs (35) had any effect
on the hydrogen peroxide-induced dephosphorylation of DNA
ligase IIIa (data not shown). In contrast, hydrogen peroxide-
induced dephosphorylation of DNA ligase IIIa was greatly
attenuated in AT ﬁbroblasts that harbor mutations in the
ATM gene (Figure 6B). As expected, this defect was corrected
in the AT ﬁbroblast cell line complemented by expression of
wild type ATM cDNA (Figure 6B), conﬁrming the participa-
tion of the ATM kinase in the oxidative stress-induced dephos-
phorylation of DNA ligase IIIa.
The steady state level of protein phosphorylation is deter-
mined by the opposing actions of kinases and phosphatases.
Treatment of an S phase-enriched population of HeLa cells
with hydrogen peroxide resulted in a marked reduction of
Cdk2 activity (Figure 7, upper panel). By contrast, the
DNA alkylating agent EMS did not signiﬁcantly affect
Cdk2 activity (Figure 7, upper panel). This prompted us to
examine whether the inhibition of Ckd2 activity by oxidative
stress was dependent upon ATM., Hydrogen peroxide treat-
ment did not result in inhibition Cdk2 activity in ATM-
deﬁcient cells (Figure 7, middle panel) but this effect was
restored by expression of wild type ATM in the mutant
cells (Figure 7, lower panel). Together these results show
that Cdk2 kinase activity is inhibited by an ATM-dependent
pathway that is activated by hydrogen peroxide.
DISCUSSION
Mammalian DNA ligase IIIa participates in nuclear base
excision and single-strand break repair pathways that play a
Figure 7. Oxidative stress inhibits Cdk2 activity in an ATM-dependent
manner. Cdk2 was immunoprecipitated from extracts of S phase-enriched
HeLa cells, and ATM-deficient (pEBS7-FT) and ATM-complemented
(pEBS7-YZ5) cells that had been treated with either hydrogen peroxide
(H2O2) or EMS (EMS) as described in Materials and Methods. Immunopre-
cipitated Cdk2 was incubated with purified histone H1 (Sigma) and
[g-
32P]ATP. After separation by SDS–PAGE, total histione H1 was
visualized by Coomassie blue staining (H1, upper panel) and labeled histone
H1 by phosphorimager analysis (
32P, middle panel). Cdk2 protein in the
immunoprecipitates was detected by imuunoblotting (lower panel, Cdk2).
Figure 6. ATM mediates DNA ligase IIIa dephosphorylation induced by
Oxidative damage. (A) S phase-enriched HeLa cells were treated with
hydrogen peroxide (H2O2) either in the presence or absence of wortmannin as
indicated. (B) ATM-deficient (pEBS7-FT) and ATM-complemented (pEBS7-
YZ5) cell lines were either mock treated or treated with hydrogen peroxide
(H2O2) as described in Materials and Methods section. DNA ligase III was
detected in cell extracts by immunoblotting.
Nucleic Acids Research, 2006, Vol. 34, No. 20 5727critical role in the repair of DNA damage in non-dividing
cells (20,36). In this study, we show that DNA ligase IIIa
is phosphorylated by the cell cycle kinase, Cdk2 both
in vitro and in vivo. The major site in DNA ligase IIIa phos-
phorylated by Cdk2 is Ser123. We have puriﬁed recombinant
DNA ligase IIIb from baculovirus-infected insect cells that
often reiterate the post translational modiﬁcations of mamma-
lian proteins. This protein had similar biochemical properties
to unmodiﬁed DNA ligase IIIb puriﬁed from E.coli (28,29),
suggesting that phosphorylation does not signiﬁcantly impact
catalytic activity. In support of this idea, Ser123 is not located
within the conserved C-terminal catalytic domain of DNA
ligase III. Previously we have shown that an N-terminal frag-
ment of DNA ligase IIIa encompassing Ser123 interacts with
both poly(ADP-ribose) polymerase 1 and poly (ADP-ribose)
(30), suggesting that Ser123 phosphorylation may regulate
the binding of DNA ligase IIIa with poly(ADP-ribose) poly-
merase 1 and possibly other protein partners. Although this
modiﬁcation does not appear to affect complex formation
with XRCC1, it is possible that it reﬂects the switching off
of housekeeping repair pathways involving DNA ligase
IIIa/XCCC1, such as short patch BER, that operate in non-
dividing cells when replication-associated repair pathways,
such as long patch BER, are activated. This would not impact
the participation of free XRCC1 in S phase repair pathways
that may be mediated via its interaction with PCNA (20,37).
If phosphorylation of DNA ligase IIIa in an unperturbed S
phase turns off its repair function, a likely response to DNA
damage would be the reactivation of this enzyme. Consistent
with this idea, DNA damage induces the dephosphoryla-
tion of phosphorylated DNA ligase IIIa. Since DNA ligase
III-deﬁcient CHO cells exhibit hypersensitivity to simple
DNA alkylating agents (30), it was surprising that oxidative
stress rather than DNA alkyalting agents was more effective
at inducing DNA ligase IIIa dephosphorylation. However,
the notion that DNA ligase IIIa plays a critical role in the
repair of oxidative DNA damage is supported by protein–
protein interactions between the subunits of the DNA ligase
IIIa /XRCC1 complex and the DNA glycosylases, OGG1
and NEIL1 that repair oxidized base lesions via different
BER subpathways (12,14).
Previous studies have shown that there is increased oxida-
tive stress in atm cells suggesting that the lack of the ATM
kinase disrupts cellular redox homeostasis (38–40). Here
we show that oxidative stress-induced dephosphorylation of
DNA ligase IIIa is dependent upon the ATM kinase. These
results suggest that ATM is activated by oxidative stress
and are consistent with emerging evidence that ATM may
sense other cellular changes in addition to DNA breaks
(41). The ATM-dependent dephosphorylation of DNA ligase
IIIa is likely to involve two distinct mechanisms. As has been
observed previously in Xenopus egg extracts (42), activation
of ATM results in the inhibition of Cdk2. In addition, it has
been shown recently that protein phosphatase PP1is activated
by IR in an ATM-dependent manner (43). Thus we suggest
that oxidative stress-induced dephosphorylation of DNA
ligase IIIa is a consequence of Cdk2 inhibition and the
activation of a cellular phosphatase such as PP1.
It has been hypothesized that DNA damage caused by
oxygen free radicals may contribute to cancer formation,
neurodegeneration and aging. Here we have shown that
DNA ligase IIIa, a key enzyme in the BER and single strand
break repair, is modiﬁed in response to oxidative stress in
an ATM-dependent manner. Since cerebellar ataxia is a
characteristic symptom of ataxia telangiectasia (44) and,
recently, defects in single-strand break repair have been
linked with hereditary forms of spinocerebellar ataxia (45),
our results contribute to the emerging evidence that the repair
of oxidative DNA damages, such as base lesions and single
strand breaks, protects against neurodegeneration.
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